Delgado Acosta F, Jiménez Gómez E, de Asís Bravo Rodríguez F, Oteros Fernández R, Ochoa Sepúlveda J J
Sección de Neurorradiología Diagnóstica y Terapeútica, Hospital Reina Sofía, Córdoba, España.
Sección de Neurorradiología Diagnóstica y Terapeútica, Hospital Reina Sofía, Córdoba, España.
Radiologia. 2014 Jan-Feb;56(1):44-51. doi: 10.1016/j.rx.2012.01.006. Epub 2012 Jul 6.
To evaluate the recanalization rate and clinical outcome three months after endovascular treatment for vertebrobasilar occlusion before the placement of stentrievers.
We reviewed all cases of basilar thrombosis treated with endovascular techniques at our center. We reviewed the clinical outcomes with the main objective of determining the recanalization rate and the secondary objective of evaluating the outcome using the modified Rankin scale (mRS) three months after treatment. We assessed clinical and angiographic variables and correlated them with outcome and complications.
We reviewed a total of 27 consecutive patients (mean age, 58.1±15.5 y; median National Institutes of Health Stroke Scale (NIHSS), 21, interquartile range, 18-29; median Glasgow coma score (GCS) 7, interquartile range, 4-9.5). The mean time between the onset of symptoms and endovascular treatment was 26.3±41.7hours. Complete or partial recanalization was achieved in 23 (85.1%) patients. Three months after treatment, 16 (59.2%) had died and 6 (22.2%) had good outcome (mRS ≤ 2).
Endovascular treatment achieved a high rate of recanalization of occlusions of the basilar artery. Nevertheless, a high percentage of the patients did not have a good outcome. New materials might improve the prognosis in these patients.
评估在使用取栓支架前，椎基底动脉闭塞血管内治疗三个月后的再通率及临床结局。
我们回顾了本中心所有采用血管内技术治疗基底动脉血栓形成的病例。我们回顾临床结局，主要目的是确定再通率，次要目的是在治疗三个月后使用改良Rankin量表（mRS）评估结局。我们评估了临床和血管造影变量，并将它们与结局及并发症相关联。
我们共回顾了27例连续患者（平均年龄58.1±15.5岁；美国国立卫生研究院卒中量表（NIHSS）中位数为21，四分位间距为18 - 29；格拉斯哥昏迷量表（GCS）中位数为7，四分位间距为4 - 9.5）。症状发作至血管内治疗的平均时间为26.3±41.7小时。23例（85.1%）患者实现了完全或部分再通。治疗三个月后，16例（59.2%）患者死亡，6例（22.2%）患者预后良好（mRS≤2）。
血管内治疗实现了基底动脉闭塞的高再通率。然而，高比例患者预后不佳。新材料可能改善这些患者的预后。
